Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

NewAmsterdam Pharma Company N.V. Warrant (NAMSW)

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/23/2022

Market Cap

1,530,261,081

Shares Outstanding

81,560,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NAMS --.--%

SCLXW --.--%

GRNAW --.--%

OABIW --.--%

ROIVW --.--%

Beta

0.0090

Last Div

0.0000

Range

0.99-14.67

Chg

0.1200

Avg Vol

4243

Mkt Cap

1530261081

Exch

NASDAQ

Country

NL

Phone

31 35 206 2971

DCF Diff

11.4026

DCF

4.9274

Div Yield

0.0000

P/S

162.6336

EV Multiple

-17.4566

P/FV

3.9920

Div Yield %

0.0000

P/E

-38.6601

PEG

-0.5324

Payout

0.0000

Current Ratio

9.8297

Quick Ratio

9.8297

Cash Ratio

9.5064

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

138506.2226

CCC

-138506.2226

Gross Margin

0.9985

Op Margin

-6.7832

Pretax Margin

-4.4232

Net Margin

-4.4262

Eff Tax Rate

0.0842

ROA

-0.0896

ROE

-0.1081

ROCE

-0.1527

NI/EBT

1.0007

EBT/EBIT

0.6521

EBIT/Rev

-6.7832

Debt Ratio

0.0013

D/E

0.0015

LT Debt/Cap

0.0008

Total Debt/Cap

0.0014

Int Coverage

0.0000

CF/Debt

-284.1895

Equity Multi

1.1529

Rec Turnover

0.0000

Pay Turnover

0.0026

Inv Turnover

0.0000

FA Turnover

11.4701

Asset Turnover

0.0202

OCF/Share

-1.6863

FCF/Share

-1.6900

Cash/Share

4.5476

OCF/Sales

-17.6706

FCF/OCF

1.0022

CF Coverage

-284.1895

ST Coverage

-682.5405

CapEx Coverage

-456.5736

Div&CapEx Cov

-456.5736

P/BV

3.9920

P/B

3.9920

P/S

162.6336

P/E

-38.6601

P/FCF

-9.1835

P/OCF

-9.6838

P/CF

-9.6838

PEG

-0.5324

P/S

162.6336

EV Multiple

-17.4566

P/FV

3.9920

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 13, 22:16 NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares GlobeNewswire Inc. Dec 12, 02:37 NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants GlobeNewswire Inc. Oct 04, 20:30 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation